SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 4

The Effects of Antenatal Steroid Treatment on Preterm Infants’ Early Laboratory Analysis

Gülsüm ŞIMŞEK
H. KUTMAN
Fuat CANPOLAT
Pages
433–437
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

White blood counts (WBC) significantly decreased, whereas the platelet counts were higher in the AST group.Serum C-reactive protein (CRP) and Interleukin-6 (IL-6) levels did not differ between groups.Conclusion: We did not demonstrate any relationship between inflammatory markers and antenatal steroid treatment in preterm infants

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We assessed the effects of antenatal steroid treatment on preterm laboratory analysis conducted in the first 24hours of life.Methods: Medical records of inborn preterm infants whose gestational age was ≤32 weeks were retrospectively reviewed in thisstudy.
📊
Key Findings & Data:Preterm infants whose mothers received antenatal betamethasone treatment of either 12 mg or 24 mg and who did notwere divided into two groups.
💡
Conclusion & Impact:White blood counts (WBC) significantly decreased, whereas the platelet counts were higher in the AST group.Serum C-reactive protein (CRP) and Interleukin-6 (IL-6) levels did not differ between groups.Conclusion: We did not demonstrate any relationship between inflammatory markers and antenatal steroid treatment in preterm infants
🔬Design:Review & Systematic Survey
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: We assessed the effects of antenatal steroid treatment on preterm laboratory analysis conducted in the first 24hours of life.Methods: Medical records of inborn preterm infants whose gestational age was ≤32 weeks were retrospectively reviewed in thisstudy. Preterm infants whose mothers received antenatal betamethasone treatment of either 12 mg or 24 mg and who did notwere divided into two groups. Maternal and neonatal demographic characteristics, all preterm morbidities and mortality rates,early laboratory examinations were compared between the two groups.Results: Medical records of 603 infants between 2008 and 2013 were retrospectively reviewed. Data from 515 infants were analyzed. Three hundred and four infants (n=304) were in the antenatal steroid treatment (AST) group and 211 infants were in thegroup that did not receive the treatment. The incidence of preeclampsia and oligohydramnios was significantly higher in the ASTgroup. Intubation in the delivery room rates decreased in the AST group. APGAR scores at five minutes were significantly higherin the AST group. White blood counts (WBC) significantly decreased, whereas the platelet counts were higher in the AST group.Serum C-reactive protein (CRP) and Interleukin-6 (IL-6) levels did not differ between groups.Conclusion: We did not demonstrate any relationship between inflammatory markers and antenatal steroid treatment in preterm infants

🔖

Cite This Article

ŞIMŞEK, G., KUTMAN, H., CANPOLAT, F. (2020). The Effects of Antenatal Steroid Treatment on Preterm Infants’ Early Laboratory Analysis. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 4, 433–437. https://ajindex.com/articles/363680

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3:CD004454
  2. The American College of Obstetricians and Gynecologists (ACOG). Committee Opinion on Antenatal Steroids. Available at: www. acog.org/More-Info/AntenatalCorticosteroids. Accessed Oct 26, 2020
  3. Özkan H, Erdeve Ö, Kutman HGK. Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment. Turk Pediatri Ars 2018;53:S45–54
  4. Zhang H, Liu J, Liu T, Wang Y, Dai W. Antenatal maternal medication administration in preventing respiratory distress syndrome of premature infants: A network meta-analysis. Clin Respir J 2018;12:2480–90
  5. Truog WE, Kessler DL, Murphy J, Standaert TA, Woodrum DE, Hodson WA. Antenatal glucocorticoid administration: effects on oxygen-hemoglobin affinity and hemoglobin levels in experimental hyaline membrane disease. Gynecol Obstet Invest 1983;15:251–7
  6. Visconti K, Senthamaraikannan P, Kemp MW, Saito M, Kramer BW, Newnham JP, et al. Extremely preterm fetal sheep lung responses to antenatal steroids and inflammation. Am J Obstet Gynecol 2018;218:349.e1–349.e10
  7. Barak M, Cohen A, Herschkowitz S. Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr 1992;81:760–3
  8. Caldas JP, Vilela MM, Braghini CA, Mazzola TN, Marba ST. Antenatal maternal corticosteroid administration and markers of oxidative stress and inflammation in umbilical cord blood from very low birth weight preterm newborn infants. J Pediatr (Rio J) 2012;88:61–6
  9. Correa-Rocha R, Pérez A, Lorente R, Ferrando-Martínez S, Leal M, Gurbindo D, et al. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7. Pediatr Res 2012;71:590–7
  10. Kumar P, Venners SA, Fu L, Pearson C, Ortiz K, Wang X. Association of antenatal steroid use with cord blood immune biomarkers in preterm births. Early Hum Dev 2011;87:559–64
  11. Agakidis C, Sarafidis K, Tzimouli V, Agakidou E, Taparkou A, Kanakoudi-Tsakalidou F, et al. Antenatal betamethasone does not influence lymphocyte apoptosis in preterm neonates. Am J Perinatol 2009;26:485–90
  12. Kavelaars A, van der Pompe G, Bakker JM, van Hasselt PM, Cats B, Visser GH, et al. Altered immune function in human newborns after prenatal administration of bet